Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Jonathan A. Fletcher, M.D.

Co-Author

This page shows the publications co-authored by Jonathan Fletcher and Paola Dal Cin.
Connection Strength

1.582
  1. Variant translocations involving 16q22 and 17p13 in solid variant and extraosseous forms of aneurysmal bone cyst. Genes Chromosomes Cancer. 2000 Jun; 28(2):233-4.
    View in: PubMed
    Score: 0.227
  2. 14-3-3 fusion oncogenes in high-grade endometrial stromal sarcoma. Proc Natl Acad Sci U S A. 2012 Jan 17; 109(3):929-34.
    View in: PubMed
    Score: 0.127
  3. Reporting of diagnostic cytogenetic results. Curr Protoc Hum Genet. 2011 Jul; Appendix 1:1D.
    View in: PubMed
    Score: 0.122
  4. Reporting of diagnostic cytogenetic results. Curr Protoc Hum Genet. 2010 Oct; Appendix 1:1D.1-23.
    View in: PubMed
    Score: 0.116
  5. Distinctive cytogenetic profile in benign metastasizing leiomyoma: pathogenetic implications. Am J Surg Pathol. 2007 May; 31(5):737-43.
    View in: PubMed
    Score: 0.092
  6. Aneurysmal bone cyst variant translocations upregulate USP6 transcription by promoter swapping with the ZNF9, COL1A1, TRAP150, and OMD genes. Oncogene. 2005 May 12; 24(21):3419-26.
    View in: PubMed
    Score: 0.080
  7. Reporting of diagnostic cytogenetic results. Curr Protoc Hum Genet. 2004 Nov; Appendix 1:Appendix 1D.
    View in: PubMed
    Score: 0.077
  8. USP6 (Tre2) fusion oncogenes in aneurysmal bone cyst. Cancer Res. 2004 Mar 15; 64(6):1920-3.
    View in: PubMed
    Score: 0.074
  9. BRD4 bromodomain gene rearrangement in aggressive carcinoma with translocation t(15;19). Am J Pathol. 2001 Dec; 159(6):1987-92.
    View in: PubMed
    Score: 0.063
  10. PLAG1 alterations in lipoblastoma: involvement in varied mesenchymal cell types and evidence for alternative oncogenic mechanisms. Am J Pathol. 2001 Sep; 159(3):955-62.
    View in: PubMed
    Score: 0.062
  11. Re: O'Sullivan MJ, Kyriakos M, Zhu X, Wick MR, Swanson PE, Dehner LP, Humphrey PA, Pfeifer JD: malignant peripheral nerve sheath tumors with t(X;18). A pathologic and molecular genetic study. Mod pathol 2000;13:1336-46. Mod Pathol. 2001 Jul; 14(7):733-7.
    View in: PubMed
    Score: 0.061
  12. PLAG1 fusion oncogenes in lipoblastoma. Cancer Res. 2000 Sep 01; 60(17):4869-72.
    View in: PubMed
    Score: 0.058
  13. TPM3-ALK and TPM4-ALK oncogenes in inflammatory myofibroblastic tumors. Am J Pathol. 2000 Aug; 157(2):377-84.
    View in: PubMed
    Score: 0.057
  14. ZMYM2-FGFR1 fusion as secondary change in acute myeloid leukemia. Leuk Lymphoma. 2019 02; 60(2):556-558.
    View in: PubMed
    Score: 0.050
  15. Reporting of Diagnostic Cytogenetic Results. Curr Protoc Hum Genet. 2016 Apr 01; 89:A.1D.1-A.1D.23.
    View in: PubMed
    Score: 0.042
  16. Gender-Specific Molecular and Clinical Features Underlie Malignant Pleural Mesothelioma. Cancer Res. 2016 Jan 15; 76(2):319-28.
    View in: PubMed
    Score: 0.041
  17. Ewing sarcoma mimicking atypical carcinoid tumor: detection of unexpected genomic alterations demonstrates the use of next generation sequencing as a diagnostic tool. Cancer Genet. 2014 Jul-Aug; 207(7-8):335-9.
    View in: PubMed
    Score: 0.038
  18. Cyclin D1 as a diagnostic immunomarker for endometrial stromal sarcoma with YWHAE-FAM22 rearrangement. Am J Surg Pathol. 2012 Oct; 36(10):1562-70.
    View in: PubMed
    Score: 0.033
  19. The clinicopathologic features of YWHAE-FAM22 endometrial stromal sarcomas: a histologically high-grade and clinically aggressive tumor. Am J Surg Pathol. 2012 May; 36(5):641-53.
    View in: PubMed
    Score: 0.032
  20. Cytogenetics and fluorescence in situ hybridization as adjuncts to cytology in the diagnosis of malignant mesothelioma. Cancer. 2009 Aug 25; 117(4):247-53.
    View in: PubMed
    Score: 0.027
  21. c-Jun amplification and overexpression are oncogenic in liposarcoma but not always sufficient to inhibit the adipocytic differentiation programme. J Pathol. 2009 Jul; 218(3):292-300.
    View in: PubMed
    Score: 0.027
  22. Molecular genetic characterization of the EWS/CHN and RBP56/CHN fusion genes in extraskeletal myxoid chondrosarcoma. Genes Chromosomes Cancer. 2002 Dec; 35(4):340-52.
    View in: PubMed
    Score: 0.017
  23. Upper respiratory tract carcinoma with chromosomal translocation 15;19: evidence for a distinct disease entity of young patients with a rapidly fatal course. Cancer. 2001 Sep 01; 92(5):1195-203.
    View in: PubMed
    Score: 0.015
  24. Diagnostic gold standard for soft tissue tumours: morphology or molecular genetics? Histopathology. 2001 Jul; 39(1):100-3.
    View in: PubMed
    Score: 0.015
  25. Frequent fusion of the JAZF1 and JJAZ1 genes in endometrial stromal tumors. Proc Natl Acad Sci U S A. 2001 May 22; 98(11):6348-53.
    View in: PubMed
    Score: 0.015
  26. Various regions within the alpha-helical domain of the COL1A1 gene are fused to the second exon of the PDGFB gene in dermatofibrosarcomas and giant-cell fibroblastomas. Genes Chromosomes Cancer. 1998 Oct; 23(2):187-93.
    View in: PubMed
    Score: 0.013
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.